| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_38f6403d850a1fe9e34ef7fd5a010318
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e3d1031395419a2f6c3637c81acdde65 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 |
| filingDate |
2011-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab997ba2d8543e5d5193199c70e83c0c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3132f8891b99198f5f19ca7119524c08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5265f3613239e497c48ef5e4fce04c3f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ac8b8777e1729814e13f536698b7c33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed4d22c84a9cc64b6b363d72e14b98a3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aab85b492c2c1db9e366edd839e73e7d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c73c544fda13f7e20307a416c51cbfca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7618e1cc4c812410a869f0cf1176505 |
| publicationDate |
2013-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2593460-A1 |
| titleOfInvention |
7, 9-nitrogen radical-4-oxo-4h-pyrido[l,2-a]pyrimidine-2-carboxylic acid benzylamide anti-virals |
| abstract |
The present invention provides a compound of Formula I or a pharmaceutically acceptable derivative, salt or prodrug thereof. Further provided is a method of treatment or prophylaxis of a viral infection in a subject comprising administering to said subject an effective amount of a compound of Formula I or a pharmaceutically acceptable derivative, salt or prodrug thereof. A pharmaceutical composition or medicament comprising a compound of Formula I is also provided |
| priorityDate |
2010-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |